IJS Global GEFCO UK gains pharma authorisation for Heathrow facility
04 / 07 / 2016
IJS Global GEFCO UK has been granted Wholesale Dealer Authorisation (WDA) by the UK Regulatory Body, the MHRA, for its operations at the London Heathrow site with immediate effect.
To sell or supply medicines to anyone other than the patient using the medicine, you need a wholesaler licence – also known as a wholesale dealer licence or wholesale distribution authorisation.
To qualify for a wholesale licence, you must comply with good distribution practice (GDP) and pass regular inspections of your site.
“In an increasingly demanding environment for distribution of medicinal products, obtaining a WDA reconfirms our commitment to offering the highest possible quality standards in support of our customers’ evolving requirements,” said Josette Wells, director – quality and compliance, IJS Global GEFCO UK.
“This licence is another step forward in our drive to establish an enhanced services platform for the Life Sciences and Healthcare industry.”
GDP status was also awarded to IJS Global GEFCO Netherlands in April this year
Internationally accepted GDP guidelines play a key role in assuring transport and distribution of medicinal products for human use does not adversely impact product quality and integrity.
The GDP guidelines focus on well-established pharmaceutical working procedures, and continuously improving distribution and handling expertise.
IJS Global GEFCO’s operations in the Netherlands already have WDA certification. Both countries are now able to store medicinal products in full compliance of EU regulations.